VTRS: Viatris Inc. Stock

by  •  • Comments Off on VTRS: Viatris Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 10,328.40
Enterprise Value ($M) 23,759.40
Book Value ($M) 15,650.40
Book Value / Share 13.33
Price / Book 0.66
NCAV ($M) -13,202.10
NCAV / Share -11.25
Price / NCAV -0.78

Profitability (mra)
Return on Invested Capital (ROIC) -0.13
Return on Assets (ROA) -0.08
Return on Equity (ROE) -0.19

Liquidity (mrq)
Quick Ratio 0.97
Current Ratio 1.68

Balance Sheet (mrq) ($M)
Current Assets 9,622.40
Assets 38,474.90
Liabilities 22,824.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 14,739.30
Operating Income 1,409.10
Net Income -634.20
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 2,302.90
Cash from Investing 1,800.70
Cash from Financing -4,330.40

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2 days ago 13G Price T Rowe Associates Inc /md/ 6.30
8 days ago 13G/A Davis Selected Advisers 6.00 3.80

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
2025-04-30 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-15 3,940,491 13,040,291 30.22
2025-05-14 2,742,648 10,364,792 26.46
2025-05-13 2,276,254 7,235,686 31.46
2025-05-12 2,979,455 9,431,039 31.59

(click for more detail)

Similar Companies
VIR – Vir Biotechnology, Inc. VOR – Vor Biopharma Inc.
VRTX – Vertex Pharmaceuticals Incorporated VTYX – Ventyx Biosciences, Inc.
VYGR – Voyager Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io